市场调查报告书
商品编码
1494780
到 2030 年手指和关节移植市场预测:按产品、材料、固定、设计、年龄组、应用、最终用户和地区进行的全球分析Digit Joint Implants Market Forecasts to 2030 - Global Analysis By Product, Material, Fixation, Design, Age Group, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球关节移植市场规模为 7,238 万美元,预计到 2030 年将达到 1.2409 亿美元,预测期内复合年增长率为 9.4%。
指趾关节移植是一种义肢装置,用于替换或加强受损或故障的指关节。这些植入通常由金属或陶瓷等耐用材料製成,模仿自然关节的结构和功能,从而改善受影响手指的活动性和功能。透过恢復手指的活动范围和稳定性,指趾关节移植可以改善手部功能受损人士的生活品质并促进日常生活活动。
根据 NCBI 2022 年 5 月更新的资料,骨关节炎影响全球约 3.3-3.6% 的人口,估计导致 4,300 万人出现中度至重度残疾。
外伤增加
事故、运动相关事件或职业危害等造成的创伤通常会导致指关节严重受损,需要手术介入才能恢復功能。指趾关节移植透过替换或修復受损关节提供了可行的解决方案,使患者能够重新获得活动能力和灵活性。由于外伤的持续发生,手指和关节移植的需求预计将增加并推动市场成长。
併发症的风险
指趾关节移植併发症的风险由多种因素引起,包括感染、植入失败和神经损伤。这些併发症可能导致恢復时间更长、需要额外的手术并降低患者满意度。这样的结果不仅增加了医疗成本,也削弱了病患对手术和植入装置的信任。因此,患者可能会选择替代治疗或完全推迟寻求医疗干预,从而阻碍市场成长。
材料科学的持续创新
材料科学领域的持续技术创新在推动关节移植市场的成长中发挥着至关重要的作用。生物相容性金属、陶瓷和生物分解性聚合物等材料的进步正在开发更耐用、生物相容性和更具功能性的植入。这些创新使外科医生能够为指关节疾病患者提供更有效的治疗方法,从而改善手术结果和患者满意度。此外,材料科学领域的持续研发工作确保了下一代植入的诞生,并透过改进产品供应和治疗功效推动市场进一步扩张。
替代治疗方案
关节关节移植的替代治疗方法包括非手术方法,例如物理治疗、疼痛管理和生活方式改变。儘管这些替代疗法可以暂时缓解症状,但它们通常无法有效解决潜在的关节损伤。因此,患者可能会推迟手术或完全避免手术,从而影响对手指和关节移植的需求。此外,喜欢非侵入性方法的患者可能不愿意考虑手术干预,这限制了市场潜力。
COVID-19 的影响
COVID-19 的爆发对手指和关节移植市场产生了各种影响。由于手术延迟和人们对医疗保健需求的认识提高,对包括关节关节重建在内的整形外科手术的需求激增,同时也造成了供应链中断和获得医疗保健设施的挑战。此外,经济不确定性和医疗保健优先事项的变化也影响着患者的决策和医疗保健支出。整体而言,市场经历了供需动态波动,疫情对市场的影响既有正面影响,也有负面影响。
生物分解性植入产业预计将在预测期内成为最大的产业
生物分解性植入领域预计将出现良好的成长。生物分解性的植入是一种很有前途的人工关节移植,随着时间的推移,它会在体内逐渐降解,从而无需进行切除手术。这些植入由聚合物和陶瓷等材料製成,可提供临时支撑,同时促进组织再生。潜在的好处包括降低感染风险和改善癒合。
骨关节炎领域预计在预测期内复合年增长率最高
骨关节炎领域预计在预测期内复合年增长率最高。对于骨关节炎,手指和关节移植可恢復功能并缓解疼痛,尤其是手指关节。随着骨关节炎的进展,软骨劣化,导致关节僵硬不适。指趾关节移植提供了一种可行的治疗选择,可以增加关节活动度并改善整体手部功能和患者的生活品质。
预计亚太地区在预测期内将占据最大的市场占有率。人口老化、关节炎和手部损伤等疾病盛行率上升以及医疗基础设施的改善是主要驱动因素。此外,技术和手术技术的进步正在扩大治疗选择并改善患者的治疗效果。中国、日本和印度等国家由于患者人数众多且医疗保健支出不断增加,正在成为利润丰厚的市场。
由于人口老化中创伤性损伤和退化性关节疾病的盛行率不断增加,预计北美在预测期内将呈现最高的复合年增长率。植入技术的进步和对微创手术的日益偏好进一步刺激了市场成长。此外,医疗保健支出的增加和患者意识的提高也有助于该地区市场的持续扩张。
According to Stratistics MRC, the Global Digit Joint Implants Market is accounted for $72.38 million in 2024 and is expected to reach $124.09 million by 2030 growing at a CAGR of 9.4% during the forecast period. Digit joint implants are prosthetic devices used to replace or augment damaged or dysfunctional finger joints. Typically composed of durable materials like metal or ceramic, these implants mimic the structure and function of natural joints, enabling improved mobility and functionality in the affected digits. By restoring range of motion and stability to the fingers, digit joint implants can enhance quality of life and facilitate activities of daily living for individuals with compromised hand function.
According to the data updated by NCBI in May 2022, it is estimated that osteoarthritis affects about 3.3 to 3.6% of the population globally and it causes moderate to severe disability in 43 million people, making it the 11th most debilitating disease worldwide.
Rising prevalence of traumatic injuries
Traumatic injuries, such as those resulting from accidents, sports-related incidents, or occupational hazards, often lead to severe damage to finger joints, necessitating surgical intervention for restoration of function. Digit joint implants offer a viable solution by replacing or repairing damaged joints, enabling patients to regain mobility and dexterity. As traumatic injuries continue to occur, the demand for digit joint implants is expected to increase, driving market growth.
Risk of complications
The risk of complications in digit joint implants arises from various factors such as infection, implant failure, and nerve damage. These complications can lead to prolonged recovery periods, additional surgeries, and decreased patient satisfaction. Such outcomes not only increase healthcare costs but also erode patient confidence in the procedure and the implanted devices. Consequently, it hampers market growth as patients may opt for alternative treatments or delay seeking medical intervention altogether.
Continuous innovations in material science
Continuous innovations in material science play a pivotal role in propelling the growth of the digit joint implants market. Advancements in materials such as biocompatible metals, ceramics, and biodegradable polymers have led to the development of implants with enhanced durability, biocompatibility, and functionality. These innovations enable surgeons to provide more effective treatment options for patients with digit joint disorders, leading to improved surgical outcomes and patient satisfaction. Moreover, ongoing R&D efforts in material science ensure the creation of next-generation implants, driving further market expansion through improved product offerings and treatment efficacy.
Alternative treatment options
Alternative treatment options to digit joint implants include non-surgical approaches like physical therapy, pain management, and lifestyle modifications. While these alternatives may offer temporary relief, they often fail to address the underlying joint damage effectively. Consequently, patients may postpone or avoid surgery altogether, impacting the demand for digit joint implants. Additionally, the preference for non-invasive methods can deter patients from considering surgical interventions, limiting the market potential.
Covid-19 Impact
The covid-19 pandemic has had a mixed impact on the digit joint implants market. While there has been a surge in demand for orthopedic procedures, including joint replacements, due to postponed surgeries and increased awareness of healthcare needs, there have also been disruptions in the supply chain and challenges in accessing healthcare facilities. Additionally, economic uncertainties and shifting healthcare priorities have influenced patient decisions and healthcare expenditure. Overall, the market has experienced fluctuations in demand and supply dynamics, with both positive and negative impacts attributable to the pandemic.
The biodegradable implants segment is expected to be the largest during the forecast period
The biodegradable implants segment is estimated to have a lucrative growth. Biodegradable implants are a promising type of digit joint implant that gradually degrades within the body over time, eliminating the need for removal surgeries. Made from materials like polymers or ceramics, these implants provide temporary support while promoting tissue regeneration. They offer potential advantages such as reduced risk of infection and improved healing.
The osteoarthritis segment is expected to have the highest CAGR during the forecast period
The osteoarthritis segment is anticipated to witness the highest CAGR growth during the forecast period. In the context of osteoarthritis, digit joint implants offer relief by restoring function and alleviating pain in affected joints, particularly in the fingers. As osteoarthritis progresses, cartilage deteriorate, leading to joint stiffness and discomfort. Digit joint implants provide a viable treatment option, enhancing joint mobility and improving overall hand function and patients' quality of life.
Asia Pacific is projected to hold the largest market share during the forecast period. Rising geriatric population, increasing prevalence of conditions like arthritis and hand injuries, and improving healthcare infrastructure are key drivers. Moreover, advancements in technology and surgical techniques are expanding treatment options and enhancing patient outcomes. Countries such as China, Japan, and India are emerging as lucrative markets due to large patient populations and increasing healthcare spending.
North America is projected to have the highest CAGR over the forecast period, owing to the increasing prevalence of traumatic injuries and degenerative joint diseases among the aging population. Advancements in implant technology and a growing preference for minimally invasive procedures further stimulate market growth. Further, rising healthcare expenditure and improving patient awareness contribute to sustained market expansion in the region.
Key players in the market
Some of the key players profiled in the Digit Joint Implants Market include Johnson & Johnson Medical Devices Company, Wright Medical Group, Teijin Nakashima Medical Corporation, Smith & Nephew, Stryker Corporation, Integra Lifesciences, Acumed LLC, Merete Medical GmbH, Zimmer Biomet Holdings Inc., Vilex in Tennessee Inc., Signature Orthopedics Implants, Anika Therapeutics, Beznoska, Skeletal Dynamics, in2bones and Evolutis.
In September 2023, Stryker launched minimally invasive surgical bunion treatment. The new technology features MIS joint preparation, triplanar reduction and a three-screw construct that creates a tension band for biomechanical stability.
In May 2022, CONMED Corporation signed a definitive agreement to acquire privately-held In2Bones Global, Inc. In2Bones is a global developer, manufacturer, and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, elbow) and lower (foot and ankle) extremities. The company's comprehensive product portfolio includes implants, fracture systems, biologics, and related hardware.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.